Concepedia

Publication | Open Access

EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE

DOIFull Paper Access

122

Citations

42

References

2017

Year

Timothy Y. Y. Lai, Giovanni Staurenghi, Paolo Lanzetta, Frank G. Holz, Shiao Hui Melissa Liew, Sabine Desset-Brèthes, Harry Staines, Philip Hykin
Retina

Abstract

Ranibizumab 0.5 mg resulted in clinically significant treatment effect versus sham at Month 2. Overall, ranibizumab was effective in treating choroidal neovascularization of various etiologies with no new safety findings.

References

YearCitations

Page 1